Clinical trial

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT00613626

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE2

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2020-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Interventions

CisplatinDRUG · verified · RxNorm: cisplatin

EtoposideDRUG · verified · RxNorm: etoposide

PlaceboDRUG

ZD6474DRUG

Sponsors & collaborators

Hoosier Cancer Research Networklead sponsor

AstraZenecacollaborator

Mapped research locations

IndianapolisIndiana, United States3 ChicagoIllinois, United States1 PhiladelphiaPennsylvania, United States1 PortlandOregon, United States1 OmahaNebraska, United States1 NewarkDelaware, United States1 Fort WayneIndiana, United States1 South BendIndiana, United States1 EvansvilleIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00613626 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.